Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Apnea

• A Twelve-week, Double-blind, Placebo-controlled, Randomized, Parallel-group, Multicenter Study to Evaluate the Efficacy and Safety of Solriamfetol in the Treatment of Excessive Daytime Sleepiness (EDS) in Patients With Obstructive Sleep Apnea (OSA)
• CPAP Effect on the Polycythemia in Patients With Obstructive Sleep Apnea
• Managing Opioid Related Sleep Apnea With Acetazolamide
• Oxygen Therapy in Children and Adolescents With Down Syndrome and Obstructive Sleep Apnea
• Endotypic Traits and Obstructive Sleep Apnea Surgery
• Impact of Obstructive Sleep Apnea (OSA) Treatment on Blood Pressure Control in Chronic Kidney Disease
• A Study of Danavorexton in People With Obstructive Sleep Apnea After General Anesthesia for Abdominal Surgery
• Patient-centered and Neurocognitive Outcomes With Acetazolamide for Sleep Apnea
• Acetazolamide for Obstructive Sleep Apnea to Improve Heart Health
• Adipose Dysfunction, Imaging, Physiology, and Outcomes With Sodium Glucose Cotransporter 2 Inhibitor (SGLT2i) for Sleep Apnea: The ADIPOSA Study
• Identifying Sleep Apnea Patients That Best Respond to Atomoxetine Plus Oxybutynin Therapy
• Obstructive Sleep Apnea Master Protocol GPIF: A Study of Tirzepatide (LY3298176) in Participants With Obstructive Sleep Apnea
• Dexmedetomidine Versus Propofol Sedation for Drug-Induced Sleep Endoscopy in Pediatric Obstructive Sleep Apnea
• Effects of Quetiapine on Sleep and Next Day Alertness in People With Obstructive Sleep Apnea
• Vascular Endothelial Dysfunction in Sleep Apnea
• Tolterodine Relieves Overactive Bladder Symptoms in Women With Moderate-to-severe Obstructive Sleep Apnea Syndrome
• The Cardiovascular Consequences of Sleep Apnea Plus COPD (Overlap Syndrome)
• Efficacy, Safety and Tolerability of Sulthiame in Patients With Obstructive Sleep Apnea (OSA)
• A Study of Danavorexton (TAK-925) in Adults With Obstructive Sleep Apnea
• Study for Efficacy and Dose Escalation of AD313 + Atomoxetine (SEED)
• A Pilot Study of Antioxidant Therapy in Obstructive Sleep Apnea Patients
• Improving Outcomes in Pediatric Obstructive Sleep Apnea With Computational Fluid Dynamics
• Do Endotypes Predict Response and Sequelae in OSA Patients
• Effect of Caffeine on Heart Rate Variability in Newborns
• Target Weaning Oxygen to Determine Cafffeine Duration for AOP
• Solriamfetol's Effect on Cognitive Health in Apnea Participants During a Randomized Placebo-controlled Study
• A Clinical Pharmacology Study of TS-142 in Patients With Obstructive Sleep Apnea Hypopnea.
• Optimal Dosage of Acetazolamide for OSA Treatment
• A Trial to Learn More About How Well BAY2586116 Works and How Safe it is in Participants With Moderate to Severe Obstructive Sleep Apnea
• A Study to Evaluate the Respiratory Safety of Lemborexant in Adult and Elderly Participants With Moderate to Severe Obstructive Sleep Apnea, and in Adult and Elderly Participants With Moderate to Severe Chronic Obstructive Pulmonary Disease
• Crossover Trial of AD182 and AD504 in Obstructive Sleep Apnea
• Collaborative Care Model for Allergic Rhinitis With Obstructive Sleep Apnea From Prevention to Treatment.
• Dexmedetomidine Supplemented Analgesia in Patients at High-risk of Obstructive Sleep Apnea
• Crossover Trial of AD109 in Obstructive Sleep Apnea
• Metabolic Effects of Metformin Therapy in Obstructive Sleep Apnea
• f Adding Ketamine to Propofol For Drug-induced Sleep Endoscopy in Adult Patients With Obstructive Sleep Apnea
• Study of AD128 Versus Placebo in Obstructive Sleep Apnea
• Crossover Trial of AD036 in Obstructive Sleep Apnea
• Effect of AD128 to Treat Obstructive Sleep Apnea
• Study on the Safety of Drug BAY2586116 and How it Works in Patients With Obstructive Sleep Apnea (a Sleep Disorder Caused by the Narrowing and Collapse of the Airway During Sleep) Including the Blood Level of the Drug and Effect of Its Doses and Rou
• Spironolactone to Improve Apnea and Cardiovascular Markers in Obstructive Sleep Apnea Patients
• Effect of Liraglutide vs CPAP on Cardiometabolic Outcomes in Obstructive Sleep Apnea
• The Effect of Trazodone on the Severity of Obstructive Sleep Apnea in Insomnic Stroke Patients With Depression
• Medications for Obstructive Sleep Apnea In Children With Down Syndrome
• Study of TAK-925 in Participants With Obstructive Sleep Apnea (OSA) Who Are Experiencing Excessive Daytime Sleepiness (EDS) Despite Adequate Use of Continuous Positive Airway Pressure (CPAP)
• Improving 24-hour Blood Pressure in Obstructive Sleep Apnea
• Impact of Estrogen + Estradiol Receptor Alpha Modulator Therapy on Oxidative Stress in Post-menopausal Women With and Without Sleep Apnea
• Remifentanil in Children With Obstructive Sleep Apnea
• Effect of Opioids on Ventilation in Children With Obstructive Sleep Apnea
• A Novel Pharmacological Therapy for Obstructive Sleep Apnea
• Combination Pharmacological Interventions for Multiple Mechanisms of Obstructive Sleep Apnea
• Safety and Tolerability of Gefapixant (MK-7264) in Participants With Obstructive Sleep Apnea (MK-7264-039)
• Benefits of Oxytocin in Obstructive Sleep Apnea (OSA) Patients Using Continuous Positive Airway Pressure (CPAP) Machine
• Trial of AD036 in Obstructive Sleep Apnea
• A Study to Assess the Effect of Seltorexant Compared to Placebo on Respiration During Sleep in Adult Participants With Obstructive Sleep Apnea
• A Study to Investigate the Effects of ACT-541468 on Nighttime Respiratory Function in Patients With Mild to Moderate Obstructive Sleep Apnea
• The Impact of Low Flow Nocturnal Oxygen Therapy on Hospital Admissions and Mortality in Patients With Heart Failure and Central Sleep Apnea
• Positive Airway Pressure Under Apnoeic Oxygenation With Different Flow Rates in Nasal Cannula Therapy
• Impact of Sugammadex vs. Neostigmine Reversal on Post-Operative Recovery and Complications
• Effect of Dupilumab on Sleep Apnea in Patients With Rhinosinusitis
• Obstructive Sleep Apnea (OSA) Treated With a Potassium Channel Inhibitor
• Montelukast for Patients With Obstructive Sleep Apnea Syndrome
• Physiology Regarding Apnoeic Oxygenation During Nasal Cannula Therapy at Different Flow Rates
• Study to Evaluate the Respiratory Safety of Lemborexant in Adult and Elderly Healthy Subjects and Adult and Elderly Subjects With Mild Obstructive Sleep Apnea
• Impact of Tramadol and Oxycodone on Sleep Apnea
• DAW1033B2 in Obstructive Sleep Apnea
• DAW1033D in Obstructive Sleep Apnea
• Moderately Preterm Infants With Caffeine at Home for Apnea (MoCHA) Trial
• Statins and CPAP in Adipose Tissue of OSA
• Caffeine for Preterm Infants With Apnea of Prematurity(AOP)
• Decreasing Post-operative Complications of Obstructive Sleep Apnea by Introducing an Intensified Monitoring and Care Protocol
• Cerebral Blood Flow and Ventilatory Responses During Sleep in Normoxia and Intermittent Hypoxia
• Combined Upper-airway and Breathing Control Therapies for Obstructive Sleep Apnea
• Effect of Tibet Rhodiola Capsule on Hypoxia and Cardiovascular Risk Factors in Patients With Obstructive Sleep Apnea
• Impact of Oxytocin on Obstructive Sleep Apnea Induced Changes in Sleep
• Morphine in Moderate Obstructive Sleep Apnoea
• Endothelial Function in Obstructive Sleep Apnea
• Effect of Long-acting Levodopa on Obstructive Sleep Apnea in Parkinson's Disease
• Intraoperative Low-dose Ketamine Infusion for Patients With Obstructive Sleep Apnea
• Propranolol for Sleep Apnea Therapy
• Pitolisant (BF2.649) in the Treatment of Excessive Daytime Sleepiness in Patients With Obstructive Sleep Apnoea Syndrome, Treated or Not by Nasal Continuous Positive Airway Pressure, But Still Complaining of Excessive Daytime Sleepiness
• Treatment of Sleep Apnea in Patients With Cervical Spinal Cord Injury
• Sacubitril-valsartan and Heart Failure Patients : the ENTRESTO-SAS Study
• Effect of Antihypertensive Agents on Diastolic Function in Patients With Sleep Apnea
• CPAP Effect on the Progression of Diabetic Retinopathy in Patients With Sleep Apnea
• CPAP Effect on Albuminuria in Patients With Diabetic Nephropathy and Obstructive Sleep Apnea
• Apneic Oxygenation Via Nasal Cannulae: 15 L/Min vs High-Flow
• Cycloserine in the Treatment of Sleep Apnea
• Short Life Agents in Balanced Anesthesia on Obstructive Sleep Apnea Syndrome
• The Impact of Venlafaxine on Apnea Hypopnea Index in Obstructive Sleep Apnea
• Sleep Apnea in Elderly
• Obstructive Sleep Apnea and Arousal Threshold in Patients With Post-traumatic Stress Disorder
• Prophylactic Versus Therapeutic Caffeine for Apnea of Prematurity
• Etomidate Versus Ketamine for Emergency Endotracheal Intubation: a Prospective Randomized Clinical Trial
• Effect of Oxymetazoline Hydrochloride in Combination With Fluticasone Propionate on the Apnea Hypopnea Index (AHI) in Subject With Persistent Nasal Congestion and Mild Obstructive Sleep Apnea
• Impact of Intrathecal Morphine on Sleep Apnea Syndrome
• Oxytocin on HR in Sleep Apnea Patient
• Evaluation of Modafinil vs Placebo for Treatment of Anesthesia Delayed Emergence in Obstructive Sleep Apnea
• Armodafinil (Nuvigil), Postoperative Recovery of OSA (Obstructive Sleep Apnea) and Obese Patients
• Dimethyl Fumarate for Obstructive Sleep Apnea
• Effect of Desipramine on Upper Airway Collapsibility and Genioglossus Muscle Activity in Patients With Obstructive Sleep Apnea - Study B
• Ketamine Infusion for Pediatric Patients With Obstructive Sleep Apnea Syndrome (OSAS) After Tonsillectomy
• Management of Apnea in Late Preterm and Term Infants
• Effects of Metoprolol and Amlodipine on Cardiac Remodeling, Arrhythmias and Blood Pressure Variation in Hypertensive Patients With Sleep Apnea Syndrome
• Tiagabine to Enhance Slow Wave Sleep in Patients With Sleep Apnea
• Effect of Acetazolamide on Central Sleep Apnea Related to Opium Consumption
• The Impact of Arousal Threshold in Obstructive Sleep Apnea
• A Short Term Open, Randomized Cross-over Trial Exploring the Effect of Carbonic Anhydrase Inhibition by Acetazolamide on Sleep Apnea Associated Hypertension and Vascular Dysfunction
• Obesity, Sleep Apnea, and Insulin Resistance
• Steroids for Pediatric Apnea Research in Kids
• Sugammadex Compared With Neostigmin/Atropin for Neuromuscular Block Reversal in Patients With Obstructive Sleep Apnea
• Establishment of Ideal IV Sedative Regimen for Successful Fiberoptic Bronchoscopy in Assessing the Site, Severity of Sleep Apnea Syndrome
• The Use of Heliox in Obstructive Sleep Apnea Syndrome
• High Versus Low Dose of Caffeine for Apnea of Prematurity
• Ketogenic Diet Treatment of Obesity With Co-morbid Type 2 Diabetes Mellitus and/or Obstructive Sleep Apnea
• Intermittent Hypoxia 2: Cardiovascular and Metabolism
• Outcome of IV Acetaminophen Use in Laparoscopic Cholecystectomies in Patients at Risk of OSA
• Antioxidant Carbocysteine Treatment in Obstructive Sleep Apnoea Syndrome
• Single Dose Morphine and Fentanyl Added to Intrathecal Mixture on Orthopedics Patients With Undiagnosed Obstructive Sleep Apnea
• Sodium-Restricted Diet and Diuretic in the Treatment of Severe Sleep Apnea
• Etiology of Sleep Apnea-related Hyperaldosteronism - BP Treatment
• Effect of Antihypertensive Agents Over Sleep Apnea
• Intranasal Steroids for the Treatment of Nocturnal Enuresis With Associated Obstructive Sleep Apnea
• Study of Erythromycin in GER-Associated Apnea of the Newborn
• The Effects of Trazodone on Sleep Apnea Severity
• Spinal Morphine for Patients With Obstructive Sleep Apnea
• Zonisamide for the Treatment of Obstructive Sleep Apnea in Overweight/Obese Patients
• Safety and Efficacy Study of Dronabinol to Treat Obstructive Sleep Apnea
• Estimating Apnea Phenotypes From Polysomnography: Oxygen
• Sedative Effects in Obstructive Sleep Apnea
• The Endothelium Dysfunction in Patients of Obstructive Sleep Apnea Syndrome
• Investigating the Safety of Post-surgical Analgesics in Children With Obstructive Sleep Apnea
• Intranasal Mometasone in Children With Obstructive Sleep Apnea Due to Adenotonsillar Hypertrophy
• Study of Cardiovascular Disease and Obstructive Sleep Apnea
• Combination Therapy to Treat Sleep Apnea
• Dose-range Finding Study of BF2.649 Effect on Patients With Obstructive Sleep Apnea (OSA)
• Nasal Tramazoline and Dexamethazone in Obstructive Sleep Apnea (OSA) Patients Tramazoline and
• Effect of Liraglutide in Obese Subjects With Moderate or Severe Obstructive Sleep Apnoea: SCALE™ - Sleep Apnoea
• Clinical Trial of Desmopressin on Nocturia in Obstructive Sleep Apnoea Patients
• Postmenopausal Women,Treatment of Sleep Apnea and Co-morbidities
• Caffeine Citrate for the Treatment of Apnea Associated With Bronchiolitis in Young Infants
• Clinical Study of Caffeine for Apnea of Prematurity
• Caffeine in Children With Obstructive Sleep Apnea, Dose Response Study
• Dexmedetomidine and Propofol in Children With History of Obstructive Sleep Apnea
• Sleep Apnea Syndrome and Vitamin D
• Effects of Suvorexant in Participants With Obstructive Sleep Apnea (MK-4305-036)
• Cardiac Hemodynamics in Overlap Syndrome (COPD With Obstructive Sleep Apnea)
• Study to Investigate the Safety and Tolerability of AZD8848 in Butyrylcholinesterase Deficient Subjects
• Inflammatory Mediators in Obstructive Sleep Apnoea Syndrome; Mechanisms of Production and the Effect of Long Term Antioxidants Administration
• Efficacy and Safety of Adalimumab in Patients With Psoriasis and Obstructive Sleep Apnea
• Effective Treatment of Sleep Apnea in Prediabetes to Reduce Cardiometabolic Risk
• Branched-chain Aminoacids in Sleep Apnea Syndromes (ARSAS)
• The Effect of Eszopiclone on the Arousal Threshold in Sleep Apnea Syndrome
• Pharmacodynamics and Efficacy of MK-7288 in Adults With Sleep Apnea (MK-7288-010)
• Montelukast and Inhaled Nasal Steroid Tx in Adult Obstructive Sleep Apnea (OSA)
• BF2.649 in Patients With OSA, Still Complaining of EDS and Refusing to be Treated by CPAP.
• BF2.649 in Patients With OSA and Treated by CPAP But Still Complaining of EDS
• CO2 Inhalation as a New Treatment Modality for Apnea of Prematurity
• Treatment of Insomnia in Elderly Sleep Apnea Patients With Ramelteon (TAK 375)
• Effects of Antihypertensive Drugs in Patients With Hypertension and Obstructive Sleep Apnea (OSA)
• Effect of Montelukast Therapy in Obstructive Sleep Apnea(OSA) Children
• Caffeine for Apnea of Prematurity-Sleep (CAP-S) Study
• Continuous Positive Airway Pressure and Acetazolamide to Treat Sleep Apnea Syndrome Patients at Altitude
• Donepezil Treatment for Sleep Apnea Patients
• Efficacy of Oral Leukotriene in Long Term Therapy of Mild and Moderate Obstructive Sleep Apnea Syndrome in Children
• Effect of Fenofibrate on Sleep Apnea Syndrome
• Preventive Effects of Bosentan on the Systemic Cardiovascular Consequence of Sleep Apnea
• Buspirone as a Potential Treatment for Recurrent Central Apnea
• A Study of VI-0521 for the Treatment of Obstructive Sleep Apnea / Hypopnea Syndrome in Obese Adults
• Sibutramine Versus Continuous Positive Airway Pressure (CPAP)in Obstructive Sleep Apnea (OSA) Patients
• Treatment of Patients With the Obstructive Sleep Apnea Syndrome at Altitude
• Losartan in Hypertensive Men and Women With Sleep Apnea Before and on Continuous Positive Airway Pressure (CPAP) Treatment
• Metabolic Study of Women With Polycystic Ovary Syndrome and Sleep Apnea
• Drug-Induced Sleep Endoscopy for Upper Airway Evaluation in Obstructive Sleep Apnea
• Safety and Efficacy of Eszopiclone With Mild to Moderate Obstructive Sleep Apnea Syndrome (OSAS)
• Study of Pain Processing in Subjects Suffering From Obstructive Sleep Apnea
• Safety of Ramelteon in Subjects With Mild to Moderate Obstructive Sleep Apnea
• Systemic Inflammation and Obstructive Sleep Apnea Syndrome: Effect of Atorvastatin
• Nasal Decongestion and Obstructive Sleep Apnea
• Treatment of Refractory Excessive Daytime Sleepiness in Patients With Obstructive Sleep Apnea/Hypopnea Syndrome (OSA/HS) Using Nasal Continuous Positive Airway Pressure (nCPAP) Therapy (0249-015)
• Evaluation of the Effect of AVE0657 on Obstructive Sleep Apnea
• Continuous Positive Airway Pressure (CPAP) Promotion And Prognosis - the Army Sleep Apnea Program (ASAP)
• Mechanism of Action of Fluticasone Furoate in Childhood Obstructive Sleep Apnea Syndrome
• Controlled Trial on Effect of Montelukast Treatment in Children With Obstructive Sleep Apnea Syndrome
• Effect of NAC on Sleep Apnea
• Atropine for Prevention of Dysrhythmias Caused by Percutaneous Ethanol Instillation for Hepatoma Therapy
• Nasal Budesonide in Children With Rhinitis and/or Mild Obstructive Sleep Apnea Syndrome
• Efficacy and Safety of Armodafinil for Adults With Excessive Sleepiness Obstructive Sleep Apnea/Hypopnea and Depression
• A Combined Surgical and Medical Approach in Mild Sleep Apnea
• Systemic Steroids Plus Antibiotics in Sleep Apnea Syndrome in Children
• Effects of Continuous Positive Airway Pressure and Valsartan Treatments on Arterial Blood Pressure in OSAS Patients
• Polidocanol Sclerotherapy of Pharynges for Obstructive Sleep Apnea (OSA) and Snoring Subjects(SS)
• Hepatic Drug Biotransformation in Children With Obstructive Sleep Apnea
• Study of Pantoprazole for Sleepiness Associated With Acid Reflux and Sleep Apnea
• The Effect of Caffeine on Postextubation Adverse Respiratory Events in Children With Obstructive Sleep Apnea (OSA).
• Study to Assess Patient Reported Outcomes With Armodafinil Treatment for Excessive Sleepiness in Adults With Narcolepsy or Obstructive Sleep Apnea/Hypopnea Syndrome
• Vascular Pathophysiology in Obstructive Sleep Apnea
• Proton Pump Inhibitor Therapy for Mild to Moderate Obstructive Sleep Apnea
• Polycystic Ovary Syndrome (PCOS) and Sleep Apnea
• Caffeine for Apnea of Prematurity (CAP)
• Sleep Apnea: Mechanism and Cerebrovascular Consequences
• New Pharmacological Treatment for Obstructive Sleep Apnea
• PROVIGIL® (Modafinil) Treatment in Children and Adolescents With Excessive Sleepiness Associated With Narcolepsy or Obstructive Sleep Apnea/Hypopnea Syndrome
• Study of PROVIGIL ® (Modafinil) Treatment in Children and Adolescents With Excessive Sleepiness Associated With Obstructive Sleep Apnea/Hypopnea Syndrome
• Serotonin and the Upper Airway in Obstructive Sleep Apnea
• Trial of Effects of Oral Xyrem and Zolpidem on Sleep-Disordered Breathing in Obstructive Sleep Apnea Patients
• Armodafinil (CEP-10953) in Treatment of Excessive Sleepiness Associated With Obstructive Sleep Apnea/Hypopnea (OSA/H) Syndrome
• Armodafinil (CEP-10953) in Treatment of Excessive Sleepiness Associated With Obstructive Sleep Apnea/Hypopnea Syndrome(OSAHS)
• Armodafinil (CEP-10953) for Treatment of Narcolepsy, Obstructive Sleep Apnea/Hypopnea Syndrome, or Chronic Shift Work Sleep Disorder